Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo

FEBS Letters
D Yin, J G Tang

Abstract

Transfer of naked plasmid with insulin precursor DNA into skeletal muscle of streptozotocin (STZ)-induced diabetic mice through electroporation and detection of gene expression is described. Four different human insulin precursor DNA fragments were inserted into pcDNA3.1(-), downstream of a CMV promoter. Three of them, with a secretion signal sequence, succeeded in lowering blood glucose at a range of 30-50% in STZ diabetic mice. The other, with a synthetic DNA fragment encoding human proinsulin, failed. The mortality rate of very seriously STZ diabetic mice was reduced significantly by the treatment. The circulating insulin-like protein (mouse insulin, human proinsulin, or intermediates during conversion of proinsulin to insulin) level in the blood of less seriously STZ diabetic mice treated with the human preproinsulin gene with an intron was about 15-23 microU/ml, while that of STZ diabetic mice treated with empty vector was only about 6 microU/ml and that of normal mice was about 18 microU/ml. Transcription of the three human insulin precursor DNAs in mouse skeletal muscle was also detected by RT-PCR. The human preproinsulin gene with the intron showed a slightly higher potency in reducing blood glucose of mildly diabetic m...Continue Reading

References

Mar 23, 1990·Science·J A WolffP L Felgner
Jan 17, 1991·Biochimica Et Biophysica Acta·A V TitomirovE Kistanova
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·A R ThierryL C Mahan
May 14, 1993·Science·R C Mulligan
Apr 1, 1993·Journal of Cellular Biochemistry·J C Weaver
Aug 1, 1996·Archives of Histology and Cytology·S TanakaK Nakayama
Jan 13, 1997·Biochemical and Biophysical Research Communications·T MuramatsuJ Okumura
Jun 1, 1997·Transplantation Proceedings·R J BartlettC Ricordi
Mar 6, 1998·Nature Biotechnology·M P RolsJ Teissie
Sep 22, 1998·Nature Biotechnology·H Aihara, J Miyazaki
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L M MirD Scherman
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·M BettanD Scherman

❮ Previous
Next ❯

Citations

Dec 18, 2007·Preparative Biochemistry & Biotechnology·El-Rashdy M RedwanEhab A Serour
Feb 8, 2003·DNA and Cell Biology·Ann E O Trezise
Sep 20, 2012·BMC Biotechnology·Zalinah AhmadAbdul Rahman Omar
May 27, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jillian M McMahon, Dominic J Wells
Jan 27, 2016·Trends in Endocrinology and Metabolism : TEM·Rui Wei, Tianpei Hong
Apr 15, 2008·Biochemical and Biophysical Research Communications·Heather Bara, Athanassios Sambanis
Aug 30, 2008·Expert Opinion on Drug Delivery·Darin E Olson, Peter M Thulé
Mar 29, 2003·Expert Opinion on Biological Therapy·Jason G Fewell, Jeffrey L Nordstrom
Mar 15, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hyuk Sang YooSeo Young Jeong
Jan 23, 2003·The Journal of Gene Medicine·Nathalie Saidenberg-Kermanac'hMarie-Christophe Boissier
May 6, 2003·The Journal of Gene Medicine·France Croze, Gérald J Prud'homme
Nov 30, 2007·The Journal of Gene Medicine·Chi ZhangJunchuan Qin
Feb 7, 2003·Gene Therapy·Q L LuT A Partridge
Jun 9, 2019·International Journal of Molecular Sciences·Emilia Sokołowska, Agnieszka Urszula Błachnio-Zabielska
Mar 15, 2014·The Journal of Pharmacology and Experimental Therapeutics·Benjamin C YadenVenkatesh Krishnan
Feb 18, 2004·World Journal of Gastroenterology : WJG·Chen-Xia HeJing-Lun Xue
Oct 11, 2003·Biochemical and Biophysical Research Communications·Kakei YasutomiOsam Mazda
Sep 21, 2005·Diabetes Research and Clinical Practice·Tae Keun OhSeung Taik Kim
Apr 7, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wei PengJunchuan Qin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.